Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently ...

Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most ...

in uterine serous carcinoma and serous ovarian carcinoma but not in nonserous uterine cancer or benign conditions. "The ...

Ovarian cancer, often called the silent killer, presents one of the most serious health threats women face globally. Its ...

In view of the possibility that the ovarian mass was a carcinoma, however ... together with free serous fluid in the cul-de-sac. Samples of peritoneal fluid were collected and sent for ...

to better understand drivers of progression and chemoresistance in ovarian cancer. "The vast majority of patients who are diagnosed with a high-grade serous carcinoma are diagnosed at an advanced ...

The company's New Drug Application seeking accelerated approval for Avutometinib in combination with Defactinib for the treatment of recurrent KRAS mutant low-grade serous ovarian cancer has been ...

Avutometinib and defactinib target KRAS-mutated recurrent low-grade serous ovarian cancer, potentially becoming the first FDA-approved treatment for this specific cancer type. The NDA is supported by ...